Literature DB >> 19887713

Monte Carlo simulation of the neutron spectral fluence and dose equivalent for use in shielding a proton therapy vault.

Yuanshui Zheng1, Wayne Newhauser, Eric Klein, Daniel Low.   

Abstract

Neutron production is of principal concern when designing proton therapy vault shielding. Conventionally, neutron calculations are based on analytical methods, which do not accurately consider beam shaping components and nozzle shielding. The goal of this study was to calculate, using Monte Carlo modeling, the neutron spectral fluence and neutron dose equivalent generated by a realistic proton therapy nozzle and evaluate how these data could be used in shielding calculations. We modeled a contemporary passive scattering proton therapy nozzle in detail with the MCNPX simulation code. The neutron spectral fluence and dose equivalent at various locations in the treatment room were calculated and compared to those obtained from a thick iron target bombarded by parallel proton beams, the simplified geometry on which analytical methods are based. The neutron spectral fluence distributions were similar for both methods, with deeply penetrating high-energy neutrons (E > 10 MeV) being most prevalent along the beam central axis, and low-energy neutrons predominating the neutron spectral fluence in the lateral region. However, unlike the inverse square falloff used in conventional analytical methods, this study shows that the neutron dose equivalent per therapeutic dose in the treatment room decreased with distance approximately following a power law, with an exponent of about -1.63 in the lateral region and -1.73 in the downstream region. Based on the simulated data according to the detailed nozzle modeling, we developed an empirical equation to estimate the neutron dose equivalent at any location and distance in the treatment vault, e.g. for cases in which detailed Monte Carlo modeling is not feasible. We applied the simulated neutron spectral fluence and dose equivalent to a shielding calculation as an example.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887713      PMCID: PMC4120875          DOI: 10.1088/0031-9155/54/22/013

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  26 in total

1.  1990 Recommendations of the International Commission on Radiological Protection.

Authors: 
Journal:  Ann ICRP       Date:  1991

2.  Design tools for proton therapy nozzles based on the double-scattering foil technique.

Authors:  J D Fontenot; W D Newhauser; U Titt
Journal:  Radiat Prot Dosimetry       Date:  2005       Impact factor: 0.972

3.  Neutron scattered dose equivalent to a fetus from proton radiotherapy of the mother.

Authors:  Geraldine Mesoloras; George A Sandison; Robert D Stewart; Jonathan B Farr; Wen C Hsi
Journal:  Med Phys       Date:  2006-07       Impact factor: 4.071

4.  Radiological use of fast protons.

Authors:  R R WILSON
Journal:  Radiology       Date:  1946-11       Impact factor: 11.105

5.  Out-of-field dose equivalents delivered by proton therapy of prostate cancer.

Authors:  Andrew Wroe; Anatoly Rosenfeld; Reinhard Schulte
Journal:  Med Phys       Date:  2007-09       Impact factor: 4.071

Review 6.  Conversion coefficients for use in radiological protection against external radiation. Adopted by the ICRP and ICRU in September 1995.

Authors: 
Journal:  Ann ICRP       Date:  1996

7.  Flattening of proton dose distributions for large-field radiotherapy.

Authors:  A M Koehler; R J Schneider; J M Sisterson
Journal:  Med Phys       Date:  1977 Jul-Aug       Impact factor: 4.071

8.  Monte Carlo simulation of a protontherapy platform devoted to ocular melanoma.

Authors:  J Hérault; N Iborra; B Serrano; P Chauvel
Journal:  Med Phys       Date:  2005-04       Impact factor: 4.071

9.  Secondary neutron and photon dose in proton therapy.

Authors:  S Agosteo; C Birattari; M Caravaggio; M Silari; G Tosi
Journal:  Radiother Oncol       Date:  1998-09       Impact factor: 6.280

10.  Dose perturbations from implanted helical gold markers in proton therapy of prostate cancer.

Authors:  Annelise Giebeler; Jonas Fontenot; Peter Balter; George Ciangaru; Ronald Zhu; Wayne Newhauser
Journal:  J Appl Clin Med Phys       Date:  2009-01-27       Impact factor: 2.102

View more
  5 in total

1.  An analytic model of neutron ambient dose equivalent and equivalent dose for proton radiotherapy.

Authors:  Rui Zhang; Angélica Pérez-Andújar; Jonas D Fontenot; Phillip J Taddei; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  Monte Carlo and analytical model predictions of leakage neutron exposures from passively scattered proton therapy.

Authors:  Angélica Pérez-Andújar; Rui Zhang; Wayne Newhauser
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

3.  GRID-ENABLED TREATMENT PLANNING FOR PROTON THERAPY USING MONTE CARLO SIMULATIONS.

Authors:  Ravi Vadapalli; Pablo Yepes; Wayne Newhauser; Roger Lichti
Journal:  Nucl Technol       Date:  2011-07

4.  Peripheral Organ Equivalent Dose Estimation Procedure in Proton Therapy.

Authors:  Carles Domingo; Juan Ignacio Lagares; Maite Romero-Expósito; Beatriz Sánchez-Nieto; Jaime J Nieto-Camero; Jose Antonio Terrón; Leticia Irazola; Alexandru Dasu; Francisco Sánchez-Doblado
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

5.  Monte Carlo Simulations of Neutron Ambient Dose Equivalent in a Novel Proton Therapy Facility Design.

Authors:  Uwe Titt; Enzo Pera; Michael T Gillin
Journal:  Int J Part Ther       Date:  2020-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.